A Study of Invasive Hemodynamic for MACHD Registry
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
This research study is being done to provide comparative data to the Mayo Clinic Adult Congenital Heart Disease Registry.
Research Team
AE
Alexander Egbe, MBBS, MPH
Principal Investigator
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
Capacity to Consent
BMI </= 30
Systolic BP </= 140mmHg
See 3 more
Timeline
Screening
Participants are screened for eligibility to participate in the trial
2-4 weeks
Data Collection
Participants undergo invasive hemodynamic assessments to provide comparative data for the registry
1 day
1 visit (in-person)
Follow-up
Participants are monitored for safety and effectiveness after data collection
4 weeks
Treatment Details
Interventions
- Invasive Hemodynamic
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor
Trials
3,427
Recruited
3,221,000+
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Trials
3,987
Recruited
47,860,000+
Other People Viewed
By Subject
By Trial
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.